Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05630937
What this trial is testing

Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)
Nerviano Medical Sciences 31
Testing effectiveness (Phase 2)Ended earlyNCT02575339
What this trial is testing

MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerHCC
Kathy Miller 11
Testing effectiveness (Phase 2)Ended earlyNCT04442581
What this trial is testing

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
University of Washington 2
Post-approval studies (Phase 4)UnknownNCT00555334
What this trial is testing

Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 200
Not applicableUnknownNCT05520801
What this trial is testing

Primary Hepatobiliary Cancer Cohort of Central China

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Neoplasms
Tongji Hospital 2,000
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Testing effectiveness (Phase 2)Study completedNCT03510871
What this trial is testing

Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan 43
Early research (Phase 1)Looking for participantsNCT06789198
What this trial is testing

Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
University Hospital Tuebingen 20
Testing effectiveness (Phase 2)UnknownNCT05555316
What this trial is testing

TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

Who this might be right for
Liver Tumor
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07518706
What this trial is testing

Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)WithdrawnNCT03722498
What this trial is testing

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912
What this trial is testing

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Who this might be right for
Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT00039078
What this trial is testing

Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Allan Tsung
Not applicableUnknownNCT05202015
What this trial is testing

Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study

Who this might be right for
HCCHepatocellular CarcinomaMRI
Charite University, Berlin, Germany 150
Not applicableActive Not RecruitingNCT05128123
What this trial is testing

Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 1,600
Not applicableLooking for participantsNCT05994859
What this trial is testing

SIRT for Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 35
Early research (Phase 1)Study completedNCT03175679
What this trial is testing

Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Beijing YouAn Hospital 10
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Not applicableStudy completedNCT06626724
What this trial is testing

A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.

Who this might be right for
Hepatocellular Carcinoma (HCC)DGF
Jian You 131
Testing effectiveness (Phase 2)Looking for participantsNCT07489976
What this trial is testing

IIT2025-03-YANG-LIFT-HCC

Who this might be right for
Hepato Cellular Carcinoma
Ju Dong Yang 41
Next Page